title: Cerebral infarction in Duchenne muscular dystrophy.
abstract: Duchenne muscular dystrophy (DMD) is an X-linked form of muscular dystrophy characterized by progressive limb-girdle distribution of muscle weakness. Morbidity related to cardiomyopathy (CMO) is common, but cerebral infarction (CI) is relatively rare in these patients. We report a case of a pontine infarct in a patient with DMD and advanced CMO, and review the published data on CMO and CI in patients with DMD.
authors.affiliation: Department of Neurology, University of South Florida College of Medicine, 2 Tampa General Circle, Tampa, FL 33606, USA.
authors.forename: Nina
authors.initials: N
authors.lastname: Tsakadze
authors.forename: Lara W
authors.initials: LW
authors.lastname: Katzin
authors.forename: Sendhil
authors.initials: S
authors.lastname: Krishnan
authors.forename: Réza
authors.initials: R
authors.lastname: Behrouz
mesh_terms: D000293:Adolescent; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D009202:Cardiomyopathies / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D002544:Cerebral Infarction / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D038524:Diffusion Magnetic Resonance Imaging; D006801:Humans; D018810:Magnetic Resonance Angiography; D008297:Male; D020388:Muscular Dystrophy, Duchenne / Q000150:complications*; D011149:Pons / Q000098:blood supply*; D016896:Treatment Outcome; D014859:Warfarin / Q000627:therapeutic use
chemical_list: D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000925:Anticoagulants; D014859:Warfarin